SGHT: Sight Sciences Inc. Stocks News on April 3, 2025

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th

SGHT

GlobeNewswire

8 days ago

Sight Sciences to Present at the 24th Annual Needham Healthcare Conference on April 8th

SGHT

Thomson Reuters StreetEvents

a month ago

Q4 2024 Sight Sciences Inc Earnings Call

SGHT

GuruFocus.com

a month ago

Sight Sciences Inc (SGHT) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Challenges

SGHT

Zacks

a month ago

Compared to Estimates, Sight Sciences (SGHT) Q4 Earnings: A Look at Key Metrics

SGHT

Zacks

a month ago

Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance

SGHT

GlobeNewswire

a month ago

Sight Sciences Reports Fourth Quarter and Full Year 2024 Financial Results and Initiates Full Year 2025 Financial Guidance

SGHT

GuruFocus.com

a month ago

Earnings To Watch: Sight Sciences Inc (SGHT) Reports Q4 2024 Result

March 2025 Penny Stocks To Consider For Growth

SGHT

Simply Wall St.

a month ago

March 2025 Penny Stocks To Consider For Growth

SGHT

Zacks

a month ago

Will Sight Sciences, Inc. (SGHT) Report Negative Earnings Next Week? What You Should Know

Sight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual Meeting

SGHT

GlobeNewswire

a month ago

Sight Sciences to Present Comprehensive Clinical Data on the OMNI® Surgical System at the 2025 American Glaucoma Society Annual Meeting

Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025

SGHT

GlobeNewswire

a month ago

Sight Sciences to Report Fourth Quarter and Full Year 2024 Financial Results on March 5, 2025

Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day

SGHT

GlobeNewswire

2 months ago

Sight Sciences to Present at Citi’s 2025 Unplugged MedTech and Life Sciences Access Day

SGHT

MT Newswires

2 months ago

UBS Adjusts Price Target on Sight Sciences to $5 From $5.50, Keeps Buy Rating

Promising US Penny Stocks To Consider In January 2025

SGHT

Simply Wall St.

2 months ago

Promising US Penny Stocks To Consider In January 2025

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

SGHT

GlobeNewswire

3 months ago

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

SGHT

MT Newswires

3 months ago

Sight Sciences Reports Positive OMNI Surgical System Data From 36-Month Study

Sight Sciences Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System in Managing Primary Open-Angle Glaucoma

SGHT

GlobeNewswire

3 months ago

Sight Sciences Announces Real-World 36-Month Study Confirming Long-Term Effectiveness of Standalone OMNI Surgical System in Managing Primary Open-Angle Glaucoma

SGHT

MT Newswires

3 months ago

Sight Sciences' TearCare Treatment for Dry Eye Disease to Generate Cost Savings Versus Existing Prescribed Medications

Sight Sciences Announces the Results of a Budget Impact Analysis for its TearCare® System for the Treatment of Meibomian Gland Disease (“MGD”) Showing Cost Savings Over Existing Reimbursed Treatment Options

SGHT

GlobeNewswire

3 months ago

Sight Sciences Announces the Results of a Budget Impact Analysis for its TearCare® System for the Treatment of Meibomian Gland Disease (“MGD”) Showing Cost Savings Over Existing Reimbursed Treatment Options

Sight Sciences initiated with a Buy at UBS

SGHT

TipRanks

4 months ago

Sight Sciences initiated with a Buy at UBS

SGHT

MT Newswires

4 months ago

UBS Initiates Sight Sciences at Buy With $5.50 Price Target

SGHT

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 12/06/2024

SGHT

Argus Research

4 months ago

Daily – Vickers Top Buyers & Sellers for 12/04/2024

Nano Dimension Leads 3 US Penny Stocks To Consider

SGHT

Simply Wall St.

4 months ago

Nano Dimension Leads 3 US Penny Stocks To Consider

Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference

SGHT

GlobeNewswire

4 months ago

Sight Sciences to Present at the Piper Sandler 36th Annual Healthcare Conference

Inside a $400 billion bet on the brain-computer interface revolution

SGHT

Yahoo Finance

4 months ago

Inside a $400 billion bet on the brain-computer interface revolution

Sight Sciences price target lowered to $5 from $7 at Morgan Stanley

SGHT

TipRanks

5 months ago

Sight Sciences price target lowered to $5 from $7 at Morgan Stanley

Sight Sciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

SGHT

Simply Wall St.

5 months ago

Sight Sciences Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

SGHT

GuruFocus.com

5 months ago

Sight Sciences Inc (SGHT) Q3 2024 Earnings Call Highlights: Navigating Challenges with ...

SGHT

Zacks

5 months ago

Sight Sciences, Inc. (SGHT) Reports Q3 Loss, Misses Revenue Estimates

Sight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance

SGHT

GlobeNewswire

5 months ago

Sight Sciences Reports Third Quarter 2024 Financial Results and Updates its Full Year 2024 Adjusted Operating Expense Guidance

Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations

SGHT

GlobeNewswire

5 months ago

Sight Sciences Appoints MK Raheja as Executive Vice President, Research and Development and Brenton Taylor as Executive Vice President, Operations

SGHT

GuruFocus.com

5 months ago

Sight Sciences Inc (SGHT) Q3 2024 Earnings Report Preview: What To Expect

Integer (ITGR) Q3 Earnings Surpass Estimates

SGHT

Zacks

5 months ago

Integer (ITGR) Q3 Earnings Surpass Estimates

Sight Sciences to Report Third Quarter Financial Results on November 7, 2024

SGHT

GlobeNewswire

6 months ago

Sight Sciences to Report Third Quarter Financial Results on November 7, 2024

SGHT

MT Newswires

6 months ago

Sight Sciences' TearCare Treatment Improves Symptoms of Dry Eye Disease in Trial

Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial

SGHT

GlobeNewswire

6 months ago

Single TearCare® Treatment Improved Functional Visual Outcomes as well as Signs and Symptoms of Patients with Dry Eye Disease in Investigator-Initiated Trial

SGHT

Simply Wall St.

6 months ago

Institutional investors own a significant stake of 34% in Sight Sciences, Inc. (NASDAQ:SGHT)

AmEx downgraded, Texas Instruments upgraded: Wall Street's top analyst calls

SGHT

The Fly

7 months ago

AmEx downgraded, Texas Instruments upgraded: Wall Street's top analyst calls

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference

SGHT

GlobeNewswire

7 months ago

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference

SGHT

Thomson Reuters StreetEvents

8 months ago

Q2 2024 Sight Sciences Inc Earnings Call

SGHT

Zacks

8 months ago

Sight Sciences, Inc. (SGHT) Reports Q2 Loss, Tops Revenue Estimates

Sight Sciences Reports Second Quarter 2024 Financial Results and Narrows Full Year 2024 Financial Guidance

SGHT

GlobeNewswire

8 months ago

Sight Sciences Reports Second Quarter 2024 Financial Results and Narrows Full Year 2024 Financial Guidance

Integer (ITGR) Q2 Earnings Surpass Estimates

SGHT

Zacks

8 months ago

Integer (ITGR) Q2 Earnings Surpass Estimates

Sight Sciences to Report Second Quarter Financial Results on August 1, 2024

SGHT

GlobeNewswire

8 months ago

Sight Sciences to Report Second Quarter Financial Results on August 1, 2024

One Sight Sciences Insider Raised Stake By 34% In Previous Year

SGHT

Simply Wall St.

10 months ago

One Sight Sciences Insider Raised Stake By 34% In Previous Year

Sight Sciences Announces the Release of its First Sustainability Report

SGHT

GlobeNewswire

10 months ago

Sight Sciences Announces the Release of its First Sustainability Report

SGHT

MT Newswires

10 months ago

Sight Sciences Trial Results Show Improved Dry Eye Disease Signs, Symptoms for TearCare Patients Crossed Over From Restasis

Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from Restasis

SGHT

GlobeNewswire

10 months ago

Sight Sciences Announces the Publication of Twelve-Month Results of the SAHARA RCT Demonstrating Improved Signs and Symptoms of Dry Eye Disease for TearCare Patients Crossed Over from Restasis

Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma

SGHT

GlobeNewswire

10 months ago

Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma

Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference

SGHT

GlobeNewswire

a year ago

Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference

SGHT

Insider Monkey

a year ago

Sight Sciences, Inc. (NASDAQ:SGHT) Q1 2024 Earnings Call Transcript

Sight Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

SGHT

Simply Wall St.

a year ago

Sight Sciences First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags

SGHT

MT Newswires

a year ago

Sight Sciences Shares Up After Q1 Net Loss Narrows, Revenue Rises; 2024 Revenue Outlook Reaffirmed

SGHT

Thomson Reuters StreetEvents

a year ago

Q1 2024 Sight Sciences Inc Earnings Call

SGHT

Zacks

a year ago

Sight Sciences, Inc. (SGHT) Reports Q1 Loss, Tops Revenue Estimates

Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance

SGHT

GlobeNewswire

a year ago

Sight Sciences Reports First Quarter 2024 Financial Results and Reaffirms Full Year 2024 Financial Guidance

Sight Sciences awarded $34m in Alcon patent infringement case

SGHT

Medical Device Network

a year ago

Sight Sciences awarded $34m in Alcon patent infringement case

SGHT

MT Newswires

a year ago

Sector Update: Health Care Stocks Edge Higher Late Afternoon

SGHT

MT Newswires

a year ago

Sector Update: Health Care Stocks Rise in Monday Afternoon Trading

SGHT

MT Newswires

a year ago

Update: Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump

SGHT

MT Newswires

a year ago

Sight Sciences Says it Obtained $34 Million Patent Infringement Verdict Against Alcon -- Shares Jump

Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery

SGHT

GlobeNewswire

a year ago

Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma Surgery

SGHT

Simply Wall St.

a year ago

With 34% ownership, Sight Sciences, Inc. (NASDAQ:SGHT) has piqued the interest of institutional investors

Sight Sciences to Report First Quarter Financial Results on May 2, 2024

SGHT

GlobeNewswire

a year ago

Sight Sciences to Report First Quarter Financial Results on May 2, 2024

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma

SGHT

GlobeNewswire

a year ago

Sight Sciences Announces the Publication of Large-Scale, Real-World MIGS Study Demonstrating the Comprehensive Aqueous Outflow Restorative Procedure with OMNI® Surgical System Technology is Effective at Lowering Both IOP and IOP Reducing Medications at 2 Years in Patients with Glaucoma

$Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting$

SGHT

GlobeNewswire

a year ago

Sight Sciences Announces the Results of the Three-Year Prospective GEMINI Trial and the Cross-Over Phase of the SAHARA RCT at the 2024 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting

Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference

SGHT

GlobeNewswire

a year ago

Sight Sciences to Present at the Upcoming 23rd Annual Needham Healthcare Conference

SGHT

Insider Monkey

a year ago

Sight Sciences, Inc. (NASDAQ:SGHT) Q4 2023 Earnings Call Transcript

SGHT

Thomson Reuters StreetEvents

a year ago

Q4 2023 Sight Sciences Inc Earnings Call

SGHT

GuruFocus.com

a year ago

Sight Sciences Inc (SGHT) Navigates Challenges to Maintain Revenue Growth and Reduce Expenses

SGHT

Zacks

a year ago

Sight Sciences, Inc. (SGHT) Reports Q4 Loss, Tops Revenue Estimates

Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance

SGHT

GlobeNewswire

a year ago

Sight Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Initiates Full Year 2024 Financial Guidance

Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024

SGHT

GlobeNewswire

a year ago

Sight Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024

SGHT

Zacks

a year ago

Sight Sciences (SGHT) to Expand in Europe With New Launch

Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting

SGHT

GlobeNewswire

a year ago

Sight Sciences Announces European Launch of the Ergo-Series of the OMNI® Surgical System at the ESCRS Winter Meeting

Orrstown Financial Services (NASDAQ:ORRF) Has Announced A Dividend Of $0.20

SGHT

Simply Wall St.

a year ago

Orrstown Financial Services (NASDAQ:ORRF) Has Announced A Dividend Of $0.20

SOPHiA GENETICS Supports Genetic Testing in Brazil

SGHT

PR Newswire

a year ago

SOPHiA GENETICS Supports Genetic Testing in Brazil

South Plains Financial Inc's Dividend Analysis

SGHT

GuruFocus.com

a year ago

South Plains Financial Inc's Dividend Analysis

John Marshall Bancorp, Inc. Reports Higher Net Interest Margin, Strong Loan Growth and Pristine Asset Quality

SGHT

Business Wire

a year ago

John Marshall Bancorp, Inc. Reports Higher Net Interest Margin, Strong Loan Growth and Pristine Asset Quality

Apparel and Footwear Retail Stocks Q3 Results: Benchmarking Dick's (NYSE:DKS)

SGHT

StockStory

a year ago

Apparel and Footwear Retail Stocks Q3 Results: Benchmarking Dick's (NYSE:DKS)

Hanmi Financial (HAFC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

SGHT

Zacks

a year ago

Hanmi Financial (HAFC) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates

Countdown to Horizon Bancorp (HBNC) Q4 Earnings: Wall Street Forecasts for Key Metrics

SGHT

Zacks

a year ago

Countdown to Horizon Bancorp (HBNC) Q4 Earnings: Wall Street Forecasts for Key Metrics

Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital

SGHT

GlobeNewswire

a year ago

Sight Sciences Announces the Closing of up to $65 Million Senior Secured Credit Facility with Hercules Capital

Best Momentum Stock to Buy for January 19th

SGHT

Zacks

a year ago

Best Momentum Stock to Buy for January 19th

indie Semiconductor Sets Date for Fourth Quarter and 2023 Earnings Release and Conference Call

SGHT

Business Wire

a year ago

indie Semiconductor Sets Date for Fourth Quarter and 2023 Earnings Release and Conference Call

SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio

SGHT

PR Newswire

a year ago

SOPHiA GENETICS Enhances RareCyte Precision Biology Services Portfolio

3 Breakout Penny Stocks Primed for Massive Gains

SGHT

InvestorPlace

a year ago

3 Breakout Penny Stocks Primed for Massive Gains

3 Stocks to Buy in the Booming Field of Gene Editing

SGHT

InvestorPlace

a year ago

3 Stocks to Buy in the Booming Field of Gene Editing

Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares

SGHT

Business Wire

a year ago

Diversified Healthcare Trust Announces Quarterly Dividend on Common Shares

Popeyes® Expands in China with 10th Store

SGHT

GlobeNewswire

a year ago

Popeyes® Expands in China with 10th Store

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Financial Highlights

SGHT

GlobeNewswire

a year ago

Sight Sciences Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Financial Highlights

Investors in Digimarc (NASDAQ:DMRC) have seen respectable returns of 86% over the past year

SGHT

Simply Wall St.

a year ago

Investors in Digimarc (NASDAQ:DMRC) have seen respectable returns of 86% over the past year

AudioCodes Announces Fourth Quarter and Full Year 2023 Reporting Date

SGHT

PR Newswire

a year ago

AudioCodes Announces Fourth Quarter and Full Year 2023 Reporting Date

Sight Sciences Announces Withdrawal of Final LCDs on Micro-Invasive Glaucoma Surgery from Five Medicare Administrative Contractors

SGHT

GlobeNewswire

a year ago

Sight Sciences Announces Withdrawal of Final LCDs on Micro-Invasive Glaucoma Surgery from Five Medicare Administrative Contractors

Are Investors Undervaluing Viemed Healthcare, Inc. (NASDAQ:VMD) By 46%?

SGHT

Simply Wall St.

a year ago

Are Investors Undervaluing Viemed Healthcare, Inc. (NASDAQ:VMD) By 46%?

MVB Financial Corp. (NASDAQ:MVBF) is definitely on the radar of institutional investors who own 46% of the company

SGHT

Simply Wall St.

a year ago

MVB Financial Corp. (NASDAQ:MVBF) is definitely on the radar of institutional investors who own 46% of the company

DocGo Delivers Medical Services at Enchant Milwaukee’s Winter Village

SGHT

Business Wire

a year ago

DocGo Delivers Medical Services at Enchant Milwaukee’s Winter Village

Sight Sciences Announces the Publication of Successful Results of the SAHARA Randomized Controlled Clinical Trial Comparing TearCare® to Restasis® for the Treatment of Dry Eye Disease

SGHT

GlobeNewswire

a year ago

Sight Sciences Announces the Publication of Successful Results of the SAHARA Randomized Controlled Clinical Trial Comparing TearCare® to Restasis® for the Treatment of Dry Eye Disease

Burke & Herbert Financial Services Director Acquires 2.1% More Stock

SGHT

Simply Wall St.

a year ago

Latest Sight Sciences Inc. (SGHT) News on April 3, 2025

Share on Social Networks: